INTICA SYSTEMS SE (IS7.DE) Fundamental Analysis & Valuation

FRA:IS7 • DE0005874846

Current stock price

1.975 EUR
0 (0%)
Last:

This IS7.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. IS7.DE Profitability Analysis

1.1 Basic Checks

  • In the past year IS7 has reported negative net income.
  • In the past year IS7 had a positive cash flow from operations.
  • In multiple years IS7 reported negative net income over the last 5 years.
  • In the past 5 years IS7 always reported a positive cash flow from operatings.
IS7.DE Yearly Net Income VS EBIT VS OCF VS FCFIS7.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M 8M

1.2 Ratios

  • The Return On Assets of IS7 (-7.09%) is worse than 74.51% of its industry peers.
  • IS7 has a worse Return On Equity (-25.44%) than 74.51% of its industry peers.
Industry RankSector Rank
ROA -7.09%
ROE -25.44%
ROIC N/A
ROA(3y)-1.02%
ROA(5y)0.02%
ROE(3y)-3.67%
ROE(5y)-0.35%
ROIC(3y)N/A
ROIC(5y)N/A
IS7.DE Yearly ROA, ROE, ROICIS7.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10

1.3 Margins

  • IS7's Operating Margin has declined in the last couple of years.
  • IS7 has a Gross Margin of 42.26%. This is comparable to the rest of the industry: IS7 outperforms 52.94% of its industry peers.
  • In the last couple of years the Gross Margin of IS7 has remained more or less at the same level.
  • The Profit Margin and Operating Margin are not available for IS7 so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.26%
OM growth 3Y-45.56%
OM growth 5Y-27.46%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.66%
GM growth 5Y1.46%
IS7.DE Yearly Profit, Operating, Gross MarginsIS7.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. IS7.DE Health Analysis

2.1 Basic Checks

  • IS7 does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for IS7 remains at a similar level compared to 1 year ago.
  • IS7 has about the same amout of shares outstanding than it did 5 years ago.
  • The debt/assets ratio for IS7 is higher compared to a year ago.
IS7.DE Yearly Shares OutstandingIS7.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
IS7.DE Yearly Total Debt VS Total AssetsIS7.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • Based on the Altman-Z score of 1.00, we must say that IS7 is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.00, IS7 is doing worse than 78.43% of the companies in the same industry.
  • The Debt to FCF ratio of IS7 is 8.46, which is on the high side as it means it would take IS7, 8.46 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 8.46, IS7 is doing worse than 60.78% of the companies in the same industry.
  • A Debt/Equity ratio of 0.39 indicates that IS7 is not too dependend on debt financing.
  • IS7 has a Debt to Equity ratio (0.39) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 8.46
Altman-Z 1
ROIC/WACCN/A
WACC6.01%
IS7.DE Yearly LT Debt VS Equity VS FCFIS7.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M 20M

2.3 Liquidity

  • IS7 has a Current Ratio of 0.84. This is a bad value and indicates that IS7 is not financially healthy enough and could expect problems in meeting its short term obligations.
  • IS7 has a worse Current ratio (0.84) than 90.20% of its industry peers.
  • IS7 has a Quick Ratio of 0.84. This is a bad value and indicates that IS7 is not financially healthy enough and could expect problems in meeting its short term obligations.
  • IS7's Quick ratio of 0.36 is on the low side compared to the rest of the industry. IS7 is outperformed by 90.20% of its industry peers.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.36
IS7.DE Yearly Current Assets VS Current LiabilitesIS7.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. IS7.DE Growth Analysis

3.1 Past

  • IS7 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -81.18%.
  • IS7 shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.97%.
  • The Revenue has been growing slightly by 1.44% on average over the past years.
EPS 1Y (TTM)-81.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.9%
Revenue 1Y (TTM)-11.97%
Revenue growth 3Y-9.65%
Revenue growth 5Y1.44%
Sales Q2Q%1.02%

3.2 Future

  • IS7 is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.99% yearly.
  • The Revenue is expected to grow by 1.17% on average over the next years.
EPS Next Y-66.07%
EPS Next 2Y21.74%
EPS Next 3Y29.99%
EPS Next 5YN/A
Revenue Next Year-6.09%
Revenue Next 2Y-1.14%
Revenue Next 3Y1.17%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
IS7.DE Yearly Revenue VS EstimatesIS7.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M
IS7.DE Yearly EPS VS EstimatesIS7.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5

More info and screens

Find the best growth stocksShow best growing peers

3

4. IS7.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for IS7. In the last year negative earnings were reported.
  • Also next year IS7 is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IS7.DE Price Earnings VS Forward Price EarningsIS7.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IS7 indicates a somewhat cheap valuation: IS7 is cheaper than 68.63% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, IS7 is valued cheaply inside the industry as 96.08% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 2.77
EV/EBITDA 7.43
IS7.DE Per share dataIS7.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • IS7's earnings are expected to grow with 29.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.74%
EPS Next 3Y29.99%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. IS7.DE Dividend Analysis

5.1 Amount

  • IS7 does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

IS7.DE Fundamentals: All Metrics, Ratios and Statistics

INTICA SYSTEMS SE

FRA:IS7 (3/13/2026, 7:00:00 PM)

1.975

0 (0%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-25
Earnings (Next)05-25
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners60.42%
Ins Owner ChangeN/A
Market Cap8.47M
Revenue(TTM)65.79M
Net Income(TTM)-3.84M
Analysts45.71
Price Target3.06 (54.94%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-16.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-86%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.91%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.13
P/FCF 2.77
P/OCF 1.59
P/B 0.56
P/tB 0.82
EV/EBITDA 7.43
EPS(TTM)-0.92
EYN/A
EPS(NY)-0.29
Fwd EYN/A
FCF(TTM)0.71
FCFY36.12%
OCF(TTM)1.24
OCFY63.01%
SpS15.33
BVpS3.52
TBVpS2.41
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.09%
ROE -25.44%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.26%
FCFM 4.65%
ROA(3y)-1.02%
ROA(5y)0.02%
ROE(3y)-3.67%
ROE(5y)-0.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)1.7%
ROCE(5y)3.73%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-45.56%
OM growth 5Y-27.46%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.66%
GM growth 5Y1.46%
F-Score4
Asset Turnover1.21
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 8.46
Debt/EBITDA 1.36
Cap/Depr 34.76%
Cap/Sales 3.46%
Interest Coverage N/A
Cash Conversion 124.71%
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.36
Altman-Z 1
F-Score4
WACC6.01%
ROIC/WACCN/A
Cap/Depr(3y)103.63%
Cap/Depr(5y)82.04%
Cap/Sales(3y)7.51%
Cap/Sales(5y)5.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-81.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.9%
EPS Next Y-66.07%
EPS Next 2Y21.74%
EPS Next 3Y29.99%
EPS Next 5YN/A
Revenue 1Y (TTM)-11.97%
Revenue growth 3Y-9.65%
Revenue growth 5Y1.44%
Sales Q2Q%1.02%
Revenue Next Year-6.09%
Revenue Next 2Y-1.14%
Revenue Next 3Y1.17%
Revenue Next 5YN/A
EBIT growth 1Y-401.1%
EBIT growth 3Y-50.82%
EBIT growth 5Y-26.41%
EBIT Next Year783.33%
EBIT Next 3Y138.11%
EBIT Next 5YN/A
FCF growth 1Y151.93%
FCF growth 3YN/A
FCF growth 5Y-9.62%
OCF growth 1Y58.29%
OCF growth 3Y29.25%
OCF growth 5Y-6.33%

INTICA SYSTEMS SE / IS7.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for INTICA SYSTEMS SE?

ChartMill assigns a fundamental rating of 2 / 10 to IS7.DE.


What is the valuation status of INTICA SYSTEMS SE (IS7.DE) stock?

ChartMill assigns a valuation rating of 3 / 10 to INTICA SYSTEMS SE (IS7.DE). This can be considered as Overvalued.


How profitable is INTICA SYSTEMS SE (IS7.DE) stock?

INTICA SYSTEMS SE (IS7.DE) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for IS7 stock?

The Earnings per Share (EPS) of INTICA SYSTEMS SE (IS7.DE) is expected to decline by -66.07% in the next year.